Production (Stage)
BioAtla, Inc.
BCAB
$0.3896
$0.00832.18%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -43.90% | -39.17% | -27.99% | -8.74% | 19.93% |
| Gross Profit | 54.80% | 49.78% | 38.68% | 8.74% | -19.93% |
| SG&A Expenses | -11.62% | -15.83% | -13.68% | -9.96% | -14.95% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -37.63% | -34.50% | -25.04% | -9.01% | 11.08% |
| Operating Income | 46.41% | 42.98% | 33.52% | 9.01% | -11.08% |
| Income Before Tax | 48.11% | 43.48% | 34.06% | 10.28% | -8.70% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 48.11% | 43.48% | 34.06% | 10.28% | -8.70% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 48.11% | 43.48% | 34.06% | 10.28% | -8.70% |
| EBIT | 46.41% | 42.98% | 33.52% | 9.01% | -11.08% |
| EBITDA | 46.61% | 43.16% | 33.75% | 9.03% | -11.21% |
| EPS Basic | 51.05% | 44.32% | 36.01% | 17.74% | 6.75% |
| Normalized Basic EPS | 51.05% | 44.32% | 36.00% | 17.74% | 6.75% |
| EPS Diluted | 51.05% | 44.32% | 36.01% | 17.74% | 6.75% |
| Normalized Diluted EPS | 51.05% | 44.32% | 36.00% | 17.74% | 6.75% |
| Average Basic Shares Outstanding | 6.70% | 1.67% | 3.25% | 9.01% | 15.46% |
| Average Diluted Shares Outstanding | 6.70% | 1.67% | 3.25% | 9.01% | 15.46% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |